Pharmaceutical Commerce - November/December 2011 - (Page 22)

Information Technology Table 2. IT Trends From the Trading Partner Perspective New HDMA 2011-2012 HDMA Factbook finds gradual growth in IT-based collaborations By Nicholas Basta Manufacturer use of serialization 2009-2010 Use 2D barcode Yes, pilot program Yes, production-level No 2009 24% 29 47 2010 29% 29 43 if not using barcode now, plan to use within: 6 months 12 months 18 months No current plans 0 25 13 63 9 27 27 36 The 2011-2012 HDMA Factbook, a compilation and survey of distributor, manufacturer and healthcare data, has been published by the Center for Healthcare Supply Chain Research, HDMA’s research arm. The annual publication, now in its 83rd year, presents a wealth of data on HDMA member business activity, distribution volumes and the like; the Center also solicits on information transfers between manufacturers (who are associate members of HDMA) and HDMA members. These IT-related activities focus primarily on electronic data interchange (EDI) relating to order processing, financial transactions, returns and chargebacks. On one level, these data are simply the nuts and bolts of e-commerce among major manufacturers and their trading partners. But on another, they give a picture of how truly extensive information-sharing and collaboration are among these trading partners. Supply-chain and IT advisors have a constant refrain: that better collaboration will lead to better decision-making, forecasting and visibility into the marketplace. More advanced business analysts at manufacturers overlay business analytics tools on these data, thereby gaining insights into business activity on a pace that can sometimes be faster than the scrip data from information vendors like IMS Health (www.imshealth. com; although, to be sure, IMS Health can and does access the same data when working with some of its clients). Companies like Axway (www.axway.com), Integrichain (www. integrichain.com) , Model N (www.modeln. com), Valuecentric (www.valuecentric. com), SAP and its business partner Vistex (www.vistex.com) provide data cleansing and analytics based on these data sets; and some manufacturers get by with homegrown solutions, extensive spreadsheeting, or analytics tools like those from SAS Institute (www.sas.com). The 2010 picture (Table 1) shows that most manufacturers use EDI for basic transactions—invoices, purchase orders and chargebacks—with distributors, and return authorizations with reverse-logistics providers. The more granular data on sales activity—advanced shipping notice (EDI 856), product transfer (867) and product activity data (852)—are used by 50-60% of manufacturers, and only 8-10% of manufacturers plan to use these tools in the next 12 months. Although the Center has been tracking these data for several year, trends are hard to evaluate because the survey format for this information has changed since last year. Generally speaking, though, it seems that about participation in these collaborations 22 November | December 2011 www.PharmaceuticalCommerce.com has increased by about 10 percentage points in many of the key categories since 2009. With the exception of returns notifications (EDI 180), which would obviously be transmitted between manufacturers and reverse-logistics providers, manufacturers don’t seem to be very interested in exchanging data with other service providers, such as market research companies, or those involved with aligning marketing activities (discount programs—see p. 1; sample distribution; or multichannel marketing campaigns), or even healthcare-provider-related data such as medication adherence programs. In coming years, the availability of anonymized e-prescribing records, or data pulled from electronic health records (EHRs) have the promise of even clearer visibility into the marketplace. It’s going to keep IT consultants busy for years to come. CSOS, barcodes and serialization Other data from the Factbook shed light on other types of collaboration, including those mandated by DEA, such as the Controlled Substances Ordering System (CSOS). According to the Center, distributor use of CSOS (which is not mandatory; paper-based systems can still be used) has jumped from 33% in 2008 to 83% in 2010. DEA requires Table 1: Manufacturers’ use of EDI transaction sets, 2010 EDI Transaction Set Exchange with Distributors Exchange with 3rd Parties Do Not Use but plan to in next 12 mos. Do Not Use 180 810 812 816 820 832 836 840 844 845 846 849 850 852 855 856 857 861 867 889 997 Return authorization Invoice Credit/Debit adjustment Organization relationship Payment order Catalog Procurement notice Request for quotation Chargeback Bid award/change notification Inventory inquiry Chargeback reconciliation Purchase order Product activity Purchase order acknowledgement Advance ship notice Shipment billing notice Receiving advice/acceptance Product transfer Promotion announcement Functional acknowledgement 0% 84 20 ISD 61 ISD ISD ISD 81 66 ISD 69 88 57 15 50 ISD ISD 58 ISD 79 76% 0.1 13 ISD 0 ISD ISD ISD 0.1 0.1 ISD 0.1 0.1 6 0 4 ISD ISD 7 ISD 23 33% 0 27 13 17 25 25 13 0 18 22 8 0 8 30 17 22 22 9 11 0 8% 0 0 88 8 63 75 88 0 0 78 0 0 8 20 0 78 78 9 89 17 ISD: INSUFFICIENT DATA SOURCE: 2011 HDMA FACTBOOK Table 3: Barriers to electronic commerce for manufacturers, 2010 Willingness of trading partners to participate..................................................................................................... 33% Time it takes to implement changes ...........................................................................................................................25 Cost of implementation to my company....................................................................................................................17 Lack of EC education and training ................................................................................................................................. 8 Other..........................................................................................................................................................................................17 notifications of who are ordering, and then receiving shipments of, Schedule II and III substances, but has had a slow uptake since instituted in 2007. DEA also figures in another data set that the Center has collected: the use of customer location identifiers. In a truly modern and automated tracking and information system, a customer code will provide an easy way to match customers with locations and with business activity. By default (because the great majority of healthcare-provider locations are required to have them) trading partners have been using these DEA codes to identify customers. According to the center, the DEA number is in use by 100% of manufacturers and distributors. Manufacturers, under the gun to comply with “sunrise” informationsharing programs with GPOs and their member hospitals are now using the recommended Global Location Number (GLN) of the GS1 standards organization (Pharmaceutical Commerce, Sept/Oct Product Security supplement, p. 20); this is now in place for 29% of manufacturers when dealing with chain or independent pharmacies, but only 13-14% of hospitals or other customers. Much more common is the Health Industry Number (HIN), in use with 60-80% of customers. Lesser numbers of manufacturers are using the Data Universal Numbering System (DUNS) or proprietary numbering schemes. GLN, in turn, leads to preparations for serialization and e-pedigree programs. The Center’s survey (Table 2) finds that serialization pilots or programs are slowly increasing, while the number of manufacturers who have no current serialization plans has declined from 63% to 36% in 2010. Both 2D barcode and RFID tags are still in contention for item serialization; but the number of barcode projects are on the increase, while 70% of manufacturers have no plans for developing RFID capability over the next year. When asked what the barriers to use of electronic commerce are (Table 3), the leading reason was the willingness of trading partners to participate. That speaks to the resistance, up and down the supply chain, for trading partners to share data, a situation that one hopes will be improving soon. The 2011-2012 Factbook is available from HDMA by visiting the HDMA Center for Healthcare Supply Chain research site, www. hc supplychainresearch.org. PC http://www.imshealth.com http://www.imshealth.com http://www.integrichain.com http://www.axway.com http://www.integrichain.com http://www.modeln.com http://www.modeln.com http://www.valuecentric.com http://www.valuecentric.com http://www.vistex.com http://www.sas.com http://www.hcsupplychainresearch.org http://www.hcsupplychainresearch.org http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - November/December 2011

Pharmaceutical Commerce - November/December 2011
Contents
Editorial
Op-Ed
Top News
Business/Finance
Brand Marketing & Communications
Supply Chain/Logistics
Information Technology
Manufacturing & Packaging
Legal & Regulatory
Meetings and Editorial Index

Pharmaceutical Commerce - November/December 2011

http://www.nxtbook.com/nxtbooks/pharmcomm/201911
http://www.nxtbook.com/nxtbooks/pharmcomm/201909
http://www.nxtbook.com/nxtbooks/pharmcomm/201906
http://www.nxtbook.com/nxtbooks/pharmcomm/201903
http://www.nxtbook.com/nxtbooks/pharmcomm/201811
http://www.nxtbook.com/nxtbooks/pharmcomm/201809
http://www.nxtbook.com/nxtbooks/pharmcomm/201806
http://www.nxtbook.com/nxtbooks/pharmcomm/20180304
http://www.nxtbook.com/nxtbooks/pharmcomm/20171112
http://www.nxtbook.com/nxtbooks/pharmcomm/20170910
http://www.nxtbook.com/nxtbooks/pharmcomm/20170708
http://www.nxtbook.com/nxtbooks/pharmcomm/20170506
http://www.nxtbook.com/nxtbooks/pharmcomm/20170304
http://www.nxtbook.com/nxtbooks/pharmcomm/20170102
http://www.nxtbook.com/nxtbooks/pharmcomm/20161112
http://www.nxtbook.com/nxtbooks/pharmcomm/20160910
http://www.nxtbook.com/nxtbooks/pharmcomm/20160708
http://www.nxtbook.com/nxtbooks/pharmcomm/20160506
http://www.nxtbook.com/nxtbooks/pharmcomm/20160304
http://www.nxtbook.com/nxtbooks/pharmcomm/20160102
http://www.nxtbook.com/nxtbooks/pharmcomm/20151112
http://www.nxtbook.com/nxtbooks/pharmcomm/20150910
http://www.nxtbook.com/nxtbooks/pharmcomm/20150708
http://www.nxtbook.com/nxtbooks/pharmcomm/20150506
http://www.nxtbook.com/nxtbooks/pharmcomm/20150304
http://www.nxtbook.com/nxtbooks/pharmcomm/20150102
http://www.nxtbook.com/nxtbooks/pharmcomm/20141112
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
http://www.nxtbook.com/nxtbooks/pharmcomm/20140910
http://www.nxtbook.com/nxtbooks/pharmcomm/20140708
http://www.nxtbook.com/nxtbooks/pharmcomm/20140506
http://www.nxtbook.com/nxtbooks/pharmcomm/20140304
http://www.nxtbook.com/nxtbooks/pharmcomm/20140102
http://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
http://www.nxtbook.com/nxtbooks/pharmcomm/20131112
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910
http://www.nxtbook.com/nxtbooks/pharmcomm/20130708
http://www.nxtbook.com/nxtbooks/pharmcomm/20130506
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
http://www.nxtbook.com/nxtbooks/pharmcomm/20130304
http://www.nxtbook.com/nxtbooks/pharmcomm/20130102
http://www.nxtbook.com/nxtbooks/pharmcomm/20121112
http://www.nxtbook.com/nxtbooks/pharmcomm/20120910
http://www.nxtbook.com/nxtbooks/pharmcomm/20120708
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
http://www.nxtbook.com/nxtbooks/pharmcomm/20120304
http://www.nxtbook.com/nxtbooks/pharmcomm/20120102
http://www.nxtbook.com/nxtbooks/pharmcomm/20111112
http://www.nxtbook.com/nxtbooks/pharmcomm/20110910
http://www.nxtbook.com/nxtbooks/pharmcomm/20110708
http://www.nxtbook.com/nxtbooks/pharmcomm/20110506
http://www.nxtbook.com/nxtbooks/pharmcomm/20110304
http://www.nxtbook.com/nxtbooks/pharmcomm/20110102
http://www.nxtbook.com/nxtbooks/pharmcomm/20101112
http://www.nxtbook.com/nxtbooks/pharmcomm/20100910
http://www.nxtbook.com/nxtbooks/pharmcomm/20100708
http://www.nxtbook.com/nxtbooks/pharmcomm/20100506
http://www.nxtbook.com/nxtbooks/pharmcomm/201004
http://www.nxtbook.com/nxtbooks/pharmcomm/201003
http://www.nxtbook.com/nxtbooks/pharmcomm/20100102
http://www.nxtbook.com/nxtbooks/pharmcomm/20091112
http://www.nxtbookMEDIA.com